Can Wang
9Patents
3h-index
40Co-inventors
53Inventor score
Filing activity: Jun 7, 2012 → Dec 9, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9266883B2 | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Chemistry; Metallurgy | 15 | Active |
| US9533988B2 | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Chemistry; Metallurgy | 12 | Active |
| US10130629B2 | Pharmaceutical combinations | Human Necessities | 3 | Active |
| US9896449B2 | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9802917B2 | Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide | Chemistry; Metallurgy | 2 | Active |
| US11208398B2 | Chemical process for preparing phenylpiperidinyl indole derivatives | Emerging Cross-Sectional Technologies | 1 | Active |
| US11578053B2 | Chemical process for preparing phenylpiperidinyl indole derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US8470878B2 | Heterocyclic sulfonamide derivatives | Chemistry; Metallurgy | 0 | Active |
| US10507201B2 | Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.